Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wail Bajhmom"'
Autor:
Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, Hani A. Aziz Jokhdar, Adel Alothman, Hanan H. Balkhy, Sameera AlJohani, Shmeylan Al Harbi, Suleiman Kojan, Majed Al Jeraisy, Ahmad M. Deeb, Ziad A. Memish, Sameeh Ghazal, Sarah Al Faraj, Fahad Al-Hameed, Asim AlSaedi, Yasser Mandourah, Ghaleb A. Al Mekhlafi, Nisreen Murad Sherbeeni, Fatehi Elnour Elzein, Abdullah Almotairi, Ali Al Bshabshe, Ayman Kharaba, Jesna Jose, Abdulrahman Al Harthy, Mohammed Al Sulaiman, Ahmed Mady, Robert A. Fowler, Frederick G. Hayden, Abdulaziz Al-Dawood, Mohamed Abdelzaher, Wail Bajhmom, Mohamed A. Hussein, and the Saudi Critical Care Trials group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://doaj.org/article/98b352d6164e45ae9eb5230477b9fe36
Autor:
Amal A. Abbas, Asma Alghamdi, Sonia Mezghani, Mourad Ben Ayed, Ahmed M. Alamori, Ghazi A. Alghamdi, Wail Bajhmom, Hanan Wajeeh, Salma S. Almutairi, Wafaa M. Radwan
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Objective. To detect biomarkers that can be used to predict COVID-19 severity to identify patients with high probability of disease progression and poor prognosis. Methods. Of the 102 patients with confirmed COVID-19 who were admitted to King Fahd Ge
Externí odkaz:
https://doaj.org/article/7d6579c4bece47b9a51b3d4a16d82350
Autor:
Hani Jokhdar, Majed Al Jeraisy, Jesna Jose, Mohamed A. Hussein, Fahad Al-Hameed, Mohamed Abdelzaher, Ahmed Mady, Sarah Al Faraj, Frederick G. Hayden, Ayed Y. Asiri, Nisreen Murad Sherbeeni, Suleiman Kojan, Wail Bajhmom, Hanan H. Balkhy, Robert A. Fowler, Abdulrahman Al Harthy, Abdullah M. Assiri, Abdullah Almotairi, Shmeylan Al Harbi, Mohammed Al Sulaiman, Yasser Mandourah, Sameera Aljohani, Asim Alsaedi, Fatehi Elzein, Ahmad M. Deeb, Ayman Kharaba, Yaseen M. Arabi, Adel Alothman, Ghaleb A. Al Mekhlafi, Ziad A. Memish, Ali Al Bshabshe, Abdulaziz Al-Dawood, Sameeh S. Ghazal
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Trials, Vol 21, Iss 1, Pp 1-8 (2020)
Abstract The MIRACLE trial (MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and intErferon-β1b) investigates the efficacy of a combination therapy of lopinavir/ritonavir and recombinant interferon-β1b provided with standard sup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0df3a786a55ef8b32a1cd2d31c3fec
https://pubmed.ncbi.nlm.nih.gov/31900204
https://pubmed.ncbi.nlm.nih.gov/31900204